Skip to main content
Equibles

STATE STREET CORP

Position in DYAI — Dyadic International Inc

CIK 93751 BOSTON, MA
Back to DYAI Full portfolio

Position in DYAI

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$38,295
+$3,404 QoQ
Shares Held
42,550
0.0% QoQ
Ownership
0.117%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#18
of 39 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority Sole 96% Shared 0% None 4%

Common Shares in DYAI Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

STATE STREET CORP holds $36,881,619,425 across 411 Biotechnology names. DYAI ranks #384 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 11,871,459 $5,896,909,829
2 REGN
Regeneron Pharmaceuticals, Inc.
 4,834,688 $3,014,621,355
3 INCY
Incyte Corp
 9,722,336 $1,102,124,008
4 MRNA
Moderna, Inc.
 15,726,193 $1,101,305,295
5 ALNY
Alnylam Pharmaceuticals, Inc.
 3,555,689 $1,070,369,059
6 RVMD
Revolution Medicines, Inc.
 4,897,051 $917,119,711
7 RPRX
Royalty Pharma plc
 12,338,229 $691,804,500
8 INSM
INSMED Inc
 6,052,174 $645,282,791

All Filings in DYAI

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $38,295 42,550
2026-03-31 $34,891 42,550
2025-12-31 $39,997 42,550
2025-09-30 $50,209 42,550
2025-06-30 $42,124 42,550
2025-03-31 $57,442 42,550
2024-12-31 $74,462 42,550
2024-09-30 $45,292 43,550
2024-06-30 $64,454 43,550
2024-03-31 $72,728 43,550
2023-12-31 $91,045 56,550
2023-09-30 $108,576 56,550
2023-06-30 $109,141 56,550
2023-03-31 $100,659 56,550
2022-12-31 $69,556 56,550
2022-09-30 $108,010 56,550
2022-06-30 $172,477 56,550
2022-03-31 $170,215 56,550
2021-12-31 $250,182 55,350
2021-09-30 $307,746 55,350
2021-06-30 $198,706 55,350
2021-03-31 $1,768,960 322,215
2020-12-31 $1,742,662 323,915
2020-09-30 $2,013,884 266,035
2020-06-30 $1,857,093 214,445